Castre, Abelardo D.
HRN: 21-33-72 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/18/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/18/2022
05/25/2022
IV
500mg
Q8H
Brain Abscess
Waiting Final Action
Indication: Empiric Type of Infection: Central Nervous System Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes